Soleno Therapeutics (SLNO) News Today → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free SLNO Stock Alerts $45.56 +0.92 (+2.06%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 7:58 AM | americanbankingnews.comSoleno Therapeutics (NASDAQ:SLNO) Trading 5.8% Higher June 7 at 1:26 AM | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $60.33 Average PT from AnalystsJune 6 at 4:18 PM | 247wallst.com3 Stocks That Have Seen Higher Share Gains Than Super Micro ComputerJune 5 at 1:42 PM | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Stock Price Up 5.8%Soleno Therapeutics (NASDAQ:SLNO) Trading 5.8% HigherJune 4, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Rating of "Buy" from BrokeragesSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) has been given a consensus recommendation of "Buy" by the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating and one has issued a strongMay 31, 2024 | marketbeat.com22,800 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Bought by Swiss National BankSwiss National Bank bought a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 22,800 shares of the company's stock, valued at approximately $918,000. Swiss National BankMay 29, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 3.1%Soleno Therapeutics (NASDAQ:SLNO) Trading 3.1% HigherMay 22, 2024 | globenewswire.comSoleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024May 22, 2024 | globenewswire.comSoleno Therapeutics to Participate in Upcoming Investor ConferencesMay 21, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Stock Price Down 5.8%Soleno Therapeutics (NASDAQ:SLNO) Trading Down 5.8%May 15, 2024 | globenewswire.comSoleno Therapeutics Stands with the Prader-Willi Syndrome CommunityMay 14, 2024 | marketbeat.comBaird R W Upgrades Soleno Therapeutics (NASDAQ:SLNO) to "Strong-Buy"Baird R W upgraded Soleno Therapeutics to a "strong-buy" rating in a research note on Friday.May 13, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) PT Lowered to $59.00Oppenheimer cut their price target on Soleno Therapeutics from $65.00 to $59.00 and set an "outperform" rating for the company in a research note on Monday.May 13, 2024 | markets.businessinsider.comSoleno Therapeutics (SLNO) Receives a Buy from Stifel NicolausMay 11, 2024 | msn.comBaird Initiates Coverage of Soleno Therapeutics (SLNO) with Outperform RecommendationMay 10, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Down 6.1%Soleno Therapeutics (NASDAQ:SLNO) Shares Down 6.1%May 10, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by AnalystsShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been given a consensus recommendation of "Buy" by the five analysts that are presently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average twelve-moMay 10, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Coverage Initiated at Robert W. BairdRobert W. Baird initiated coverage on Soleno Therapeutics in a research note on Friday. They issued an "outperform" rating and a $72.00 price target on the stock.May 10, 2024 | investorplace.comSLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024May 9, 2024 | markets.businessinsider.comSoleno Therapeutics’ DCCR Poised for FDA Approval and Blockbuster Sales: An Analyst’s Bullish OutlookMay 9, 2024 | globenewswire.comSoleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 9, 2024 | marketbeat.comVivo Capital LLC Increases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Vivo Capital LLC boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 162.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 8,418,093 shares of the company's stock after acquiring an additional 5,215,000 sMay 8, 2024 | finance.yahoo.comWhile institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the mostMay 3, 2024 | nasdaq.comSoleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hoursMay 2, 2024 | globenewswire.comSoleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common StockMay 2, 2024 | globenewswire.comSoleno Therapeutics Announces Proposed Public Offering of Common StockMay 2, 2024 | insidertrades.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Vivo Opportunity, Llc Sells 750,000 SharesApril 30, 2024 | globenewswire.comSoleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi SyndromeApril 29, 2024 | marketwatch.comSoleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide CholineApril 29, 2024 | marketwatch.comSoleno Therapeutics Shares Rise 37% After Breakthrough Designation for Diazoxide CholineApril 29, 2024 | seekingalpha.comSoleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To WatchApril 29, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37.89Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37.89April 29, 2024 | fool.comWhy Soleno Therapeutics Stock Is Skyrocketing TodayApril 29, 2024 | globenewswire.comSoleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)April 19, 2024 | globenewswire.comSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 15, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Shares Up 3.4%Soleno Therapeutics (NASDAQ:SLNO) Trading 3.4% HigherApril 14, 2024 | marketbeat.comCarlyle Group Inc. Acquires 564,242 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Carlyle Group Inc. increased its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 24.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,857,804 shares of the company's stock after acquiriApril 5, 2024 | investing.comSoleno Therapeutics CEO sells over $780k in company stockApril 4, 2024 | insidertrades.comInsider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells 2,218 Shares of StockApril 4, 2024 | finance.yahoo.comInsider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)April 4, 2024 | finance.yahoo.comCEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)April 4, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Kristen Yen Sells 2,218 SharesSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) insider Kristen Yen sold 2,218 shares of the company's stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $91,692.12. Following the sale, the insider now directly owns 23,422 shares of the company's stock, valued at approximately $968,265.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.March 31, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Sees Large Increase in Short InterestSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 2,300,000 shares, a growth of 36.9% from the February 29th total of 1,680,000 shares. Based on an average trading volume of 294,800 shares, the days-to-cover ratio is presently 7.8 days. Currently, 12.2% of the company's shares are short sold.March 26, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 5.6%Soleno Therapeutics (NASDAQ:SLNO) Trading Up 5.6%March 19, 2024 | marketbeat.comWalleye Capital LLC Takes $1.37 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Walleye Capital LLC purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 46,244 shares of the company's stock, valued at approximately $1,365,000. Walleye Capital LLC owned 0.March 16, 2024 | finance.yahoo.comSLNO Apr 2024 40.000 putMarch 16, 2024 | finance.yahoo.comSLNO Apr 2024 35.000 putMarch 12, 2024 | marketbeat.comSchonfeld Strategic Advisors LLC Acquires Shares of 23,200 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Schonfeld Strategic Advisors LLC bought a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 23,200 shares of the company's stock, valued at approximateMarch 11, 2024 | bizjournals.comConstruction of Soleno's $22M pipe factory in Saratoga underwayMarch 11, 2024 | finance.yahoo.comWe're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address A New Generation of Billionaires Is About to Be Created (Ad)On June 30, AI will hit a tipping-point… $15.7 trillion of wealth is at stake. As many as 800 million jobs are caught in AI’s crosshairs… Click here for details. SLNO Media Mentions By Week SLNO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.510.72▲Average Medical News Sentiment SLNO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼52▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rhythm Pharmaceuticals News Larimar Therapeutics News Rockwell Medical News TransMedics Group News Integer News LivaNova News CONMED News InMode News BioLife Solutions News Zynex News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t...Porter & Company | SponsoredWe’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from the...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored